PCI术后造影剂脑病1例及诊疗策略  

A Case of Contrast-Induced Encephalopathy Induced by a Percutaneous Coronary Intervention and Its Diagnosis and Treatment Strategy

作　　者：吕畅 赵茜[1] 李冠青[1] 郭慧 李建国[1] 

机构地区：[1]河北省人民医院急诊医学科,河北 石家庄

出　　处：《临床医学进展》2019年第11期1334-1338,共5页Advances in Clinical Medicine

摘　　要：目的:通过病例报道认识造影剂脑病的诊疗策略。方法:回顾分析1例经皮冠状动脉介入治疗术导致造影剂脑病的临床资料,分析其致病原因、临床表现、诊治策略和预后。结果:造影剂脑病是一种少见的由造影剂引起的神经功能紊乱的不良反应,确诊后应积极治疗,可防止脑功能不可逆的损害。结论:造影剂脑病的病因复杂,应首先排除威胁生命的病症,积极处理,预后良好。Objective: To understand the diagnosis and treatment strategy of contrast encephalopathy through case reports. Methods: The clinical data of a case of contrast encephalopathy caused by percutaneous coronary intervention were retrospectively analyzed. The causes, clinical manifestations, diagnosis and treatment strategies and prognosis were analyzed. Results: Contrast encephalopathy is an adverse reaction accompanied by a neurological disorder caused by a contrast agent. Active treatment should be done after diagnosis to prevent irreversible damage to brain function. Conclusion: The etiology of contrast-enhancing encephalopathy is complex. It should first be excluded from life-threatening conditions, and then actively treated, and the prognosis is good.

关 键 词：冠状动脉介入治疗术(PCI) 造影剂脑病(CIE) 不良反应 诊疗策略 

分 类 号：R54[医药卫生—心血管疾病]